Metcalf et al.
JOCNote
ꢀ
for C9H13F3NO5S 304.0467, found 304.0512. Anal. Calcd for
ꢀ
C9H12F3NO5S: C 35.65, H 3.99. Found: C 35.74, H 3.98.
chloride by filtration, the solvent was removed in vacuo. The
product was recrystallized twice from dry THF to yield 4, 6.6 g
(28mmol,71%);mp87-90 °C(THF);1HNMR(CDCl3,300MHz)
δ 3.72 (s, 3H), 3.60 (m, 2H), 3.45 (m, 2H), 3.14 (s, 3H), 1.50-2.00
(m, 6H); 13C NMR (CDCl3, 75 MHz) δ 158.2, 76.6, 54.7, 53.3,
40.1, 21.6, 20.6; IR (KBr) v 3206.4, 2951.4, 2869.3, 2686.4, 2110.2,
1704.5, 1470.7 cm-1; LRMS (FAB þ NBA matrix) m/z 237, 205
(34.3), 100 (100.0), 70 (11.2).
N-Methyl-N-{[(2,2,2-trifluoroethyloxycarbonyl) amino]sulfonyl}-
piperidinaminium, Inner Salt (5). 2,2,2-Trifluoroethyl chlorosulfonyl-
carbamate (4.0 g, 17 mmol) in 30 mL of dry THF was added
dropwise to N-methylpiperidine (3.80 g, 38 mmol) in 20 mL of dry
THF at 0 °C. The reaction mixture was stirred for 2 h. N-Methylpiper-
idinium chloride was removed by filtration and the solvent was
removed in vacuo. The product was recrystallized twice from dry
THF to yield 5, 2.4 g (7.9 mmol, 48%); mp 79-81 °C (THF); 1H
NMR (CDCl3, 300 MHz) δ 4.48 (q, J = 8.5 Hz, 2H), 3.63 (m, 2H),
3.45 (m, 2H), 3.15 (s, 3H), 1.82-1.99 (m, 6H); 13C NMR (CDCl3,
150 MHz) δ 156.1, 123.2 (q, J = 277.8 Hz), 61.7 (q, J = 36.0 Hz),
54.8, 40.2, 21.4, 20.6; IR (KBr) v 3425.3, 2964.1, 2872.7, 2716.4,
2127.0, 1712.9, 1470.3 cm-1; LRMS (FAB þ NBA matrix) m/z
305, 205 (26.7), 137 (3.9), 100 (100.00); HRMS calcd for C9H15-
F3N2O4S 305.0783, found 305.0764.
Methyl cis-Tetrahydro-3H-1,2,3-benzoxathiazole-3-carboxy-
late 2,2-Dioxide (7). Eluent hexanes-ethyl acetate, 4:1; Rf 0.42
(2:1 hexanes-ethyl acetate); mp 145-147 °C (EtOAc); 1H
NMR (CDCl3, 600 MHz) δ 6.12 (m, 1H), 5.81 (d, 10.32 Hz,
1H), 5.21 (s, 1H), 4.80 (s, 1H), 3.93 (s, 3H), 2.35 (m, 1H), 2.30 (m,
1H), 2.15 (m, 1H), 1.92 (m, 1H); 13C NMR (CDCl3, 150 MHz)
δ 150.5, 131.6, 120.7, 77.8, 55.5, 54.6, 24.0, 18.5; IR (KBr) v
3438.9, 3010.2, 2963.5, 2853.3, 2544.9, 1725.9 cm-1; LRMS
(FAB þ NBA matrix) m/z 234, 214 (13.5), 156 (27.4), 79 (40.3);
HRMS calcd for C8H11NO4S 233.0358, found 234.0394 (Mþ þ
H). Anal. Calcd for C8H11NO5S: C 41.20, H 4.75. Found: C
41.32, H 4.75.
2,2,2-Trifluoroethyl cis-Tetrahydro-3H-1,2,3-benzoxathiazole-
3-carboxylate 2,2-Dioxide (14). Eluent hexanes-ethyl acetate, 2:1;
Rf 0.46 (2:1 hexanes-ethyl acetate); mp 70-72 °C (EtOAc);
1H NMR (CDCl3, 300 MHz) δ 6.15 (m, 1H), 5.79 (d, J = 10.2 Hz,
1H), 5.24 (s, 1H), 4.85 (s, 1H), 4.65 (m, 2H), 2.29 (m, 2H), 2.09 (m,
1H), 1.85 (m, 1H); 13C NMR (CDCl3, 75 MHz) δ 148.6, 132.3,
122.3 (q, J = 277.7 Hz), 120.1, 78.1, 62.5 (q, J = 37.6 Hz), 55.7,
27.1, 23.9, 18.5; IR (KBr) v 3492.1, 3044.8, 2982.3, 2933.8, 2853.8,
1766.9 cm-1; LRMS (EI) m/z 301, 221 (33.5), 220 (18.4), 216
(14.2), 120 (21.5), 94 (30.0), 78 (100.0); HRMS calcd for C9H10-
F3NO5S 301.0232, found 301.0229. Anal. Calcd for C9H10-
F3NO5S: C 35.88, H 3.35. Found: C 35.98, H 3.24.
Bis((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl) 1-Phenylethane-
1,2-diyldicarbamate (12). Rf 0.75 (1:1 hexanes-ethyl acetate); mp
173-75 °C (EtOAc); 1H NMR (CDCl3, 300 MHz) δ 7.36 (m, 2H),
7.29 (m, 3H), 5.72 (m, 1H), 4.82 (m, 2H), 4.56 (m, 2H), 3.52 (s, 2H),
2.01 (m, 4H), 1.69 (m, 5H), 1.51 (s, 3H), 1.32 (m, 2H), 0.75-1.20
(m, 24H);13CNMR (CDCl3, 150 MHz) δ128.7, 127.7, 126.3, 75.0,
74.8, 56.4, 47.3, 41.4, 34.3, 31.4, 26.3, 23.5, 22.0, 20.9, 16.4; IR
(KBr) v 1015.2, 1148.8, 1291.1, 1455.0, 1533.1, 1685.8, 2956.1,
3364.2 cm-1; LRMS (FAB þ NBA matrix) m/z, 501(11.3), 319
(22.1), 225 (24.3), 181 (69.9), 120 (38.0), 83 (100.0); HRMS calcd for
ꢀ
C30H49N2O4 501.3692, found 501.3691. Anal. Calcd for C30H48N2O4:
C 71.96, H 9.66, N 5.59. Found: C 71.70, H 9.78, N 5.60.
Acknowledgment. The authors are grateful to the follow-
ing agencies for support of this work: the Natural Sciences
and Engineering Research Council (NSERC, Discovery
Grant and Idea to Innovation programs), Canada Research
Chairs program, Canada Foundation for Innovation (CFI),
Ontario Partnership for Innovation and Commercialization
(OPIC), Ontario Innovation Trust (OIT), Research Corporation,
Noramco, Inc., TDC Research, Inc., TDC Research Foundation,
and Brock University.
2,2,2-Trifluoroethyl cis-Hexahydro-3H-1,2,3-benzoxathiazole-
3-carboxylate 2,2-Dioxide (13). Eluent hexanes-ethyl acetate, 2:1;
1
Rf 0.45 (2:1 hexanes-ethyl acetate); mp 83-85 °C (EtOAc); H
NMR (CDCl3, 600 MHz) δ 5.07 (d, J = 3.1 Hz, 1H), 4.69 (m, 1H),
4.61 (m, 1H), 4.27 (m, 1H), 2.38 (m, 1H), 2.33 (m, 1H), 1.90 (m,
Supporting Information Available: NMR data collection
protocol, procedure for decomposition study of Burgess re-
agents at 50 and 78 °C, general procedures for dehydration of
1,2,3,4-tetrahydro-1-naphthol and for reactions with oxiranes
and diols, and 1H and 13C NMR spectra of new Burgess reagents
and sulfamidates. This material is available free of charge via the
1H), 1.81 (m, 2H), 1.69 (m, 1H), 1.55 (m, 1H), 1.27 (m, 1H); 13
C
NMR (CDCl3, 150 MHz) δ 148.3, 122.3 (q, J = 278.8 Hz), 80.0,
62.5 (q, J= 37.6 Hz), 58.4, 27.1, 26.9, 21.8, 18.8; IR (KBr) v3031.7,
2947.2, 2871.5, 1755.5, 1623.1 cm-1; LRMS (FAB þ NBA matrix)
m/z 304, 258 (5.5), 224 (43.3), 136 (30.7), 81 (100.0); HRMS calcd
3450 J. Org. Chem. Vol. 75, No. 10, 2010